Clinical Trials · NCT07870538
A Neuropsychobiological Approach to Optimize Patient Selection for GLP-1-based Pharmacotherapy for Weight Management Across the Binge Eating Spectrum
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Enrollment
- 96
- Start date
- Aug 2026
- Locations
- 1 site, Belgium
- Primary endpoint
- Change in Body Mass Index (BMI) after semaglutide treatment